跳至主要内容
临床试验/NCT00560625
NCT00560625终止不适用

Low Dose(1mcg) ACTH Stimulation Test for Assessment of the Hypothalamus-pituitary-adrenal Axis in Patients Treated With Inhaled Busedonide or Fluticasone.

HaEmek Medical Center, Israel1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2007年5月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
50
试验地点
1
主要终点
stimulated serum cortisol levels

研究概览

简要总结

Inhaled corticosteroids are largely used in patients with asthma or chronic obstructive lung diseases. The purpose of this study is to determine if the use of inhaled corticosteroids is associated with suppression of endogenous cortisol production, as seen in patients treated with pharmacologic doses of oral or parenteral steroids.

详细描述

The normalcy of the hypothalmic-pituitary-adrenal (HPA) axis of enrolled subjects will be assessed by low dose (1mcg) corticotropin (ACTH)stimulation test. Serum cortisol levels will be measured before , 30 minutes and 60 minutes after 1 mcg ACTH intravenous injection.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients receiving inhaled busedonide or fluticasone at daily dose of 200-800 mcg ' for at least 4 weeks

排除标准

  • patients receiving any corticosteroid therapy, except inhaled busedonide or fluticasone.

结局指标

主要结局

stimulated serum cortisol levels

时间窗: within 30 days of treatment

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验